Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

The document helps doctors recognize and treat excessive hair growth in women.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.